KEYTRUDA*
- Pembrolizumab- Keytruda -@-(Sep 2014 ) - Anti-cancer
Compositions:
Pembrolizumab- mg,
List of Related Indications:
Pembrolizumab- mg,
- For the treatment of patients with unresectable or metastatic melanoma and disease progression following Ipilmimab and if BRAF V600 mutation positive a BRAF Inhibitor
Strength | Rate | Packing Style |
---|---|---|
mg | 0.00 | unit |